AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,345,607 | -12.6% | 94,772 | 0.0% | 0.01% | -11.1% |
Q2 2023 | $2,683,943 | +33.5% | 94,772 | +8.3% | 0.01% | +28.6% |
Q1 2023 | $2,010,748 | -11.4% | 87,538 | +8.3% | 0.01% | -22.2% |
Q4 2022 | $2,268,724 | -7.1% | 80,795 | -6.4% | 0.01% | -10.0% |
Q3 2022 | $2,442,000 | -4.2% | 86,349 | -1.4% | 0.01% | +25.0% |
Q1 2022 | $2,549,000 | +5.5% | 87,567 | +19.2% | 0.01% | +14.3% |
Q4 2021 | $2,415,000 | -16.7% | 73,486 | +17.0% | 0.01% | -22.2% |
Q3 2021 | $2,898,000 | +16.9% | 62,806 | +39.7% | 0.01% | +12.5% |
Q2 2021 | $2,478,000 | +13.2% | 44,961 | +6.0% | 0.01% | 0.0% |
Q1 2021 | $2,189,000 | -16.7% | 42,398 | -30.1% | 0.01% | -11.1% |
Q4 2020 | $2,627,000 | +30.5% | 60,622 | +5.4% | 0.01% | +12.5% |
Q3 2020 | $2,013,000 | -18.0% | 57,525 | +25.3% | 0.01% | -20.0% |
Q2 2020 | $2,456,000 | +8.1% | 45,926 | -28.3% | 0.01% | -9.1% |
Q1 2020 | $2,272,000 | -25.7% | 64,028 | 0.0% | 0.01% | -8.3% |
Q4 2019 | $3,057,000 | +85.4% | 64,028 | +25.8% | 0.01% | +100.0% |
Q3 2019 | $1,649,000 | – | 50,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 354,650 | $18,314,000 | 7.19% |
Casdin Capital, LLC | 2,165,000 | $111,801,000 | 3.33% |
Rock Springs Capital Management LP | 2,543,600 | $131,352,000 | 2.87% |
HealthCor Management, L.P. | 1,532,960 | $79,162,000 | 2.80% |
Bellevue Group AG | 4,537,092 | $234,295,000 | 2.48% |
Woodline Partners LP | 824,097 | $42,556,000 | 0.94% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,081,347 | $55,841,000 | 0.83% |
Integral Health Asset Management, LLC | 43,000 | $2,221,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,119,566 | $57,814,000 | 0.43% |
Virtus ETF Advisers LLC | 18,328 | $946,000 | 0.40% |